Evoxac and Hair loss - a phase IV clinical study of FDA data

Summary:

Hair loss is reported as a side effect among people who take Evoxac (cevimeline hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Xeljanz, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Hair loss when taking Evoxac. It is created by eHealthMe based on reports of 1,960 people who have side effects when taking Evoxac from the FDA, and is updated regularly.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,513 conditions by eHealthMe. Check the latest studies of Hair loss.

On Jul, 18, 2026

1,960 people reported to have side effects when taking Evoxac.
Among them, 20 people (1.02%) have Hair loss.

Among these 20 people:

How long have people been on Evoxac when they have Hair loss? *

What is the gender of people who have Hair loss when taking Evoxac? *

female: 95 %
male: 5 %

What is the age of people who have Hair loss when taking Evoxac? *

What are other drugs people take besides Evoxac? *

What are other side effects people have besides Hair loss? *

Dizziness: 8 people, 40.00%
Nausea (feeling of having an urge to vomit): 7 people, 35.00%
Migraine (headache): 6 people, 30.00%
Trichorrhexis (a condition in which the hairs break): 6 people, 30.00%
White Blood Cell Count Decreased: 5 people, 25.00%
Rashes (redness): 5 people, 25.00%
Leukopenia (less number of white blood cells in blood): 5 people, 25.00%
Fatigue (feeling of tiredness): 5 people, 25.00%
Back Pain: 4 people, 20.00%
Headache (pain in head): 4 people, 20.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 45.00%
Dry Eyes (lack of adequate tears): 6 people, 30.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 20.00%
High Blood Pressure: 3 people, 15.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 15.00%
Joint Pain: 3 people, 15.00%
Insomnia (sleeplessness): 2 people, 10.00%
Osteoporosis (bones weak and more likely to break): 2 people, 10.00%
Hypersensitivity: 2 people, 10.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Evoxac and have Hair loss?

- Check whether Hair loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evoxac:

Evoxac (2,028 reports)

Hair loss treatments and more:

Hair loss (271,201 reports)

Browse all side effects of Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair loss:

Hair loss (2,411 drugs)

Browse all the conditions that are associated with Hair loss:

Hair loss (3,513 conditions)

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cevimeline hydrochloride (the active ingredients of Evoxac) and Evoxac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.